[HTML] springer.comFull View

[HTML][HTML] Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck, FH Münch… - Critical Care, 2020 - Springer
Background There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and …
被引用次数：105 相关文章

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis.

JM Kruse, A Magomedov, A Kurreck, FH Münch… - Critical Care, 2020 - go.gale.com
Background There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and …

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis.

JM Kruse, A Magomedov, A Kurreck, FH Münch… - 2020 - cabidigitallibrary.org
Background: There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and …
[PDF] archive.org

[PDF][PDF] Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck, FH Münch… - 2020 - scholar.archive.org
Background: There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID‑19) patients, with thromboembolic complications contributing to morbidity and …

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck, FH Münch… - Critical …, 2020 - search.proquest.com
Background There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and …
[PDF] scienceopen.com

[PDF][PDF] Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck, FH Münch… - 2020 - scienceopen.com
Background: There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID‑19) patients, with thromboembolic complications contributing to morbidity and …
[HTML] nih.gov

[HTML][HTML] Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck, FH Münch… - Critical Care, 2020 - ncbi.nlm.nih.gov
Background There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and …

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck… - Critical care …, 2020 - pubmed.ncbi.nlm.nih.gov
Background There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and …
[HTML] biomedcentral.com

[HTML][HTML] Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck… - Critical …, 2020 - ccforum.biomedcentral.com
There is emerging evidence for enhanced blood coagulation in coronavirus 2019 (COVID-
19) patients, with thromboembolic complications contributing to morbidity and mortality. The …

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck, FH Münch… - Critical Care, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
There is emerging evidence for enhanced blood coagulation in coronavirus 2019 (COVID …